Since the PKP2 gene is not included in the recommended scope of DNA diagnosis for those with “low or intermediate” Schwartz probability of LQTS, we may say that, in our case, the extended genetic testing has increased the rate of accurate molecular diagnosis from 42.9 to 50% in this group of patients referred as having LQTS. Here, PKP2 is linked to familial long QT syndrome.